NCT05703711 Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa
| NCT ID | NCT05703711 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Psychosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2023-10-25 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2023-10-25 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In West Africa, most people with serious mental illness receive care from traditional or faith healers at prayer camps. The stepped-wedge cluster randomized trial aims to evaluate the effectiveness of a dual-pronged intervention package comprised of a mobile health program designed to train healers to deliver evidence-based psychosocial interventions combined with pharmacotherapy delivered directly to the patients at their prayer camps via a visiting nurse in Ghana.
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older * Speaks Twi or English * Current inpatient staying at a study prayer camp * A diagnosis of psychosis, mania, or depression Exclusion Criteria: * Serious physical illness or in need of urgent medical attention
Contact & Investigator
Dror Ben-Zeev, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT05703711 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05703711 currently recruiting?
Yes, NCT05703711 is actively recruiting participants. Contact the research team at dbenzeev@uw.edu for enrollment information.
Where is the NCT05703711 trial being conducted?
This trial is being conducted at Accra, Ghana.
Who is sponsoring the NCT05703711 clinical trial?
NCT05703711 is sponsored by University of Washington. The principal investigator is Dror Ben-Zeev, PhD at University of Washington. The trial plans to enroll 360 participants.